PRESS INFORMATION
Heading: 1st half 2017 results
Nanterre, September 6, 2017

1st half 2017 operating profit stands at 8.6%

Accounts at June 30 (audited in € millions) H1 2016 2016 H1 2017
Revenues 221.5 446.8  245
Business operating profit (*)   19.5 (8.8%)   43.5 (9.7%)   21.7 (8.9%)
Operating profit   19.1 (8.6%)   42.5 (9.5%)   21.1 (8.6%)
Net financial income   0.6   2.4 1.8
Tax on earnings   (7.1)  (15.9)   (7.7)
Net profit after tax   12.6 (5.7%)   29 (6.5%)   15.2 (6.2%)
  of which, group share   10.9   25.2   13
Staff at end of period 4,865 5,044  5,024 (**)

(*) before cost of free shares
(**) after disposal of an entity with 127 people on May 31, 2017

Achievements

With revenues up 10.6% (of which 10% on a like-for-like basis), the group experienced its 26th consecutive six-month period of growth.

Operating profit rose by 10.5% while net profit increased by 20.6%.

Over a one-year period, cashflow (excluding financial debt) increased by €17 million. On June 30, 2017, it stood at €136.7 million.

Outlook

For 2017 as a whole, NEURONES reiterates its forecast of revenues in excess of €480 million, with an operating profit rate between 9% and 9.5%.

About NEURONES

With 5,000 experts, the NEURONES group specializes in Consulting (Management, Organization and Digital) and IT Services (Infrastructures and Applications). It supports its clients in their change-management projects and in the upgrading and outsourcing of their Information Systems.

Euronext Paris (Compartment B - NRO) - Enternext Tech 40

www.neurones.net

Press Relations:
Florence Gillier Communication
Sabine Grosdidier
Tel.: +33 (0)1 41 18 85 55
sabineg@fgcom.fr
 

NEURONES
Matthieu Vautier
Tel.: +33 (0)1 41 37 41 37
rp@neurones.net
Investor Relations :
NEURONES
Paul-César Bonnel
Tel.: +33 (0)1 41 37 41 37
investisseurs@neurones.net
 



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NEURONES via Globenewswire

Source(s) : NEURONES